Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BN✓SelectedUSD · BNGSK vs BN performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs BN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
BN return
+247.9%
Excess return
-150.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioBNExcessAlpha
1D-0.1%-3.1%+2.9%+0.6%
7D-5.3%-7.9%+2.5%-3.5%
30D-3.7%+0.6%-4.3%-3.9%
3M-7.3%-8.6%+1.3%-5.4%
6M-4.2%-16.5%+12.2%-0.4%
YTD+0.9%-17.3%+18.2%+4.7%
1Y+7.3%-13.1%+20.3%+10.0%
3Y+52.7%+67.0%-14.2%+28.8%
5Y+40.1%+22.7%+17.4%+26.2%
All+97.1%+247.9%-150.9%+22.1%

Cumulative growth

Daily Returns

Daily percentage return beside BN.

Daily Out/Under-Performance

Portfolio return minus BN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded BN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling